Medication adherence and growth in children with CKD.

ABSTRACT:

Background and objectives

Poor growth is a consequence of CKD, but can often be partially or fully prevented or corrected with the use of a number of medications. The extent of nonadherence with medications used to treat or mitigate growth failure in CKD has not been examined prospectively in children with CKD.

Design, setting, participants, & measurements

The prevalence of both prescription of and nonadherence to recombinant human growth hormone (rhGH), phosphate binders, alkali, active vitamin D, nutritional vitamin D, iron, and erythrocyte-stimulating agents was summarized over the first seven visits of the Chronic Kidney Disease in Children cohort study. The association between self-reported nonadherence to each medication group and the mean annual change in age- and sex

SUBMITTER: Akchurin OM 

PROVIDER: S-EPMC4152804 | biostudies-literature | 2014 Sep

REPOSITORIES: biostudies-literature